Repair of a Complicated Calvarial Defect: Reconstruction of an Infected Wound With rhBMP-2.

Autor:	MacIsaac ZM; From the *Department of Plastic Surgery, University of Pittsburgh, Pittsburgh, PA; †Georgia Health Sciences University, Augusta, GA; ‡Division of Plastic Surgery, University of Wisconsin, Madison, WI; §Department of General Surgery, St Louis University, St Louis, MO; ∥Department of Oral Biology, and ¶Departments of Anthropology and Orthodontics, University of Pittsburgh, Pittsburgh, PA., Shakir S, Naran S, Smith DM, Cray JJ, Nayar HS, Camison L, Kinsella CR Jr, Mooney MP, Cooper GM, Losee JE
Jazyk:	angličtina
Zdroj:	Annals of plastic surgery [Ann Plast Surg] 2016 Feb; Vol. 76 (2), pp. 205-10.
DOI:	10.1097/SAP.0000000000000515
Abstrakt:	Background: Management of the previously infected craniofacial defect remains a significant clinical challenge, posing obstacles such as wound healing complications, lack of donor site availability, and predisposition to failure of the repair. Optimal therapy would reconstruct like with like, without donor site morbidity. The purpose of this study was to compare the efficacy of recombinant human bone morphogenetic protein-2 (rhBMP-2)-mediated bone regeneration with the current standard of autologous bone graft for repair of previously infected calvarial defects. Methods: Nineteen adult New Zealand white rabbits underwent subtotal calvariectomy. Bone flaps were inoculated with Staphylococcus aureus and replanted. After 1 week of infection, bone flaps were removed, and wounds were debrided, followed by 10 days of antibiotic treatment. After 6 weeks, animals underwent scar debridement followed by definitive reconstruction in 1 of 4 groups: empty control (n = 3), vehicle control (buffer solution on absorbable collagen sponge [ACS], n = 3), autologous bone graft (n = 3), or rhBMP-2 repair (rhBMP-2/ACS, n = 10). Animals underwent computed tomography imaging at 0, 2, 4, and 6 weeks postoperatively, followed by euthanization and histological analysis. Percent healing was determined by 3-dimensional analysis. A (time × group) 2-way analysis of variance was performed on healing versus treatment group and postoperative time. Results: At 6 weeks postoperatively, rhBMP-2/ACS and autologous bone graft resulted in 93% and 68% healing, respectively, whereas the empty and vehicle control treatment resulted in 27% and 26% healing (P < 0.001). Histologically, compared to autologous bone graft, bone in the rhBMP-2/ACS group was more cellular and more consistently continuous with wound margins. Conclusions: The rhBMP-2 therapy is effective in achieving radiographic coverage of previously infected calvarial defects.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu